Driving innovation
for Life Sciences in Europe

About EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology. We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.

Read more…

Upcoming Events

Our Events Section

News & Updates

EUCOPE statement on the political agreement on the EU General Pharmaceutical Legislation

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) acknowledges the provisional political agreement reached on the EU General Pharmaceutical Legislation (GPL) and recognises the efforts of the EU Institutions to modernise the pharmaceutical framework for the first time in over 20 years. This revision will have… read more

EUCOPE: Council position on the Critical Medicines Act brings improvement – but further work is needed

On 2 December 2025, EU Ministers of Health in the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) formally adopted its General Approach on the Critical Medicines Act (CMA). EUCOPE appreciates the clear distinction between measures applying to critical medicines and to medicinal products… read more

EUCOPE Publishes White Paper on Strengthening ATMP Manufacturing in Europe

EUCOPE’s Cell & Gene Therapy Working Group has published a new White Paper on ATMP Manufacturing, outlining the key barriers that innovators face in bringing advanced therapies to patients across Europe and proposing concrete solutions to strengthen Europe’s biomanufacturing landscape. The paper identifies five critical challenge areas—from… read more

SOUNDS OF SCIENCE PODCAST EPISODE #23 – Impact of EU legislations on the competitiveness of the life sciences sector

Sounds of Science – Episode 23 Competitiveness in Life Sciences: Report on Impact of EU Legislations In this episode of EUCOPE Sounds of Science, we launch the report titled Competitiveness of the EU Life Sciences Sector – Analysis of the impact of current and future EU legislations… read more

EUCOPE and Copenhagen Economics Publish New Report on the impact of EU Legislations on Life Sciences Competitiveness

Press Release Brussels, 17 November 2025 Today, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) published a new report titled Competitiveness of the EU Life Sciences Sector – Analysis of the impact of current and future EU legislations on the competitiveness of the EU life sciences… read more

EU Medical Countermeasures and Stockpiling Strategies: critical steps toward stronger health emergency preparedness

Brussels, 9 July 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) reckons both the EU Medical Countermeasures and Stockpiling Strategies, published today, as positive steps toward improving the EU’s preparedness for future health emergencies. In an increasingly uncertain geopolitical scenario, strengthening the EU medical… read more

EU Life Sciences Strategy: a step towards a stronger, innovation-friendly ecosystem

Brussels, 2 July 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) appreciates and supports the European Commission’s ambition to strengthen the EU’s healthcare ecosystem through a comprehensive EU Life Sciences Strategy. A more integrated and innovation-friendly regulatory framework is essential for the EU to… read more

SOUNDS OF SCIENCE PODCAST EPISODE #22 – Tackling Antimicrobial Resistance: EUCOPE’s Position and Industry Perspectives

Sounds of Science – Episode 22 Tackling Antimicrobial Resistance: EUCOPE’s Position and Industry Perspectives In this episode of EUCOPE Sounds of Science, the discussion centers on antimicrobial resistance (AMR), often referred to as the “silent killer” due to its escalating threat to public health and… read more

EUCOPE Member Spotlight: Q&A with Jane Cooper Senior Vice President and Region Head for Ultragenyx Europe, Middle East and Africa

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In June, we spoke with Jane Cooper Senior Vice President and Region Head for Ultragenyx Europe, Middle East and… read more

EUCOPE Response to Council Agreement on Pharma Package: Innovation must remain a priority

Brussels, 5 June 2025 – Following the negotiators in the Council having agreed their General Approach yesterday (4 June), the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) acknowledges the step forward in the legislative process and urges EU policymakers to safeguard the EU’s innovation-driven life sciences… read more

... or browse news by Tag

Patients Rare Disease Medicines innovation Regulatory Health Access Members Research COVID19 Events podcast ATMPs OMP Commission HTA Medical Devices EMA biotech Digital pharma EU Health IVDR European Commission competitiveness HERA Brexit MDR AdvancedDxs Life Science genomics European Parliament EHDS PharmaPackage Supply SoHO Regulation data act Safety GDPR clinical trial MEDTECH World Health Assembly medicine shortages RNA AMR

Our News Section

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership